Your source for breaking news, topical videos, and slides covering cardiovascular disease and interventions. Register at tctmd.com
New York, NY
- Tweets 20,897
- Following 6,649
- Followers 28,202
- Likes 7,224
A new federal program—ADVOCATE—will provide $62.7 million over 4 years to develop agentic artificial intelligence to transform cardiovascular care. Haider Warraich tells TCTMD’s Todd Neale where that work might lead. Read the full story linked here: bit.ly/4xLYnc7
@ARPA_H
3
2
365
The American Heart Association (AHA)’s @American_Heart PREVENT risk equations are now seamlessly integrated into Epic, one of the most commonly used electronic health record (EHR) systems in the United States. bit.ly/4yUqKFZ
2
2
557
Arab Americans have substantial burdens of modifiable cardiometabolic risk factors, with rates of premature atherosclerotic cardiovascular disease (ASCVD) that suggest a distinct high-risk phenotype, according to an analysis from the SALAM registry. Read more: bit.ly/4ycVemw
2
3
838
AI can help speed up the detection and diagnosis process for physicians, but how will it impact the patient care process? For Rox Heart Radio, @Drroxmehran, @AmiBhattMD, and @rohan_khera discuss the technology's influence and adoption in the field: bit.ly/3TpgEhk
4
922
HF with mildly reduced EF is gone, stages are updated, and new classifications for medical and interventional therapies are introduced in the latest European guidance. Read the full story to stay informed of all major changes: bit.ly/3TuNSvI
629
More Strokes, Especially Ischemic, With LAAO vs Medical Therapy: Meta-analysis dlvr.it/TVccHd
1
4
1,009
TCTMD retweeted
Breakthroughs start here. 💡
Be there as the #heartfailure community unites at #THT2027! 🫀 Discover the latest innovations, advances, and cutting-edge tech transforming care.
📢 Early-bird registration is OPEN! Lock in the best savings when you secure your
spot by November 10. ow.ly/og7X50ZQc2q
#CardioX #CardioTwitter #CardioEd #CardioResearch @BurkhoffMd @djc795 @ColletCarlos @jgranadacrf @PopmaJeffrey @triciarawh @akshaydesaimd @UlrichJordeMD @LindenfeldJoann @NirUrielMD @FudimMarat @TCTConference @TCTMD
2
5
1,022
PRAGUE-26 joins HI-PEITHO in supporting the use of catheter-directed
thrombolysis for patients with intermediate-high-risk PE. Experts stressed that the method is simple and can be done with existing cath lab infrastructure. Now it’s time to organize how that care is delivered. bit.ly/4dmLtKd
2
5
953
🚨NEW FDA APPROVAL🚨 The approval gives US operators a second DCB option for coronary in-stent restenosis after Agent entered the market 2-and-a-half years ago. bit.ly/4iHl8dn
2
8
4,934
The Fifth Universal Definition of Myocardial Infarction comes with many updates related to underlying pathology and more closely matches how cardiologists manage patients with suspected MI. Read the full story: bit.ly/3UWSyee
1
3
3
932
Older women with AF fared worse with LAAO than with best medical care, which mostly included DOACs, according to a sex-specific analysis of the CLOSURE-AF trial presented at #ESCCongress2026. No such difference was seen in men. Read more: bit.ly/4htIS3A
2
2
923
On Thursday, September 10th, the US Centers for Medicare & Medicaid Services (CMS) issued its finalized update to the National Coverage Determination (NCD) for TAVI and, as expected, coverage has been extended to patients with asymptomatic severe aortic stenosis. Read more: bit.ly/4h2xAmL
1
4
9
1,226
We can prevent those first events, and we can reduce your mortality," shares @rgiugliano, lead author of the new VESALIUS-CV trial analysis. Findings indicate that adding evolocumab to lipid-lowering therapy lowers mortality and reduces CV events. bit.ly/4y7aSQy
5
3,930